Ironwood Pharmaceuticals (IRWD) Short Interest Ratio & Short Volume $3.63 +0.10 (+2.83%) (As of 10:33 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Ironwood Pharmaceuticals Short Interest DataIronwood Pharmaceuticals (IRWD) has a short interest of 11.22 million shares, representing 7.20% of the float (the number of shares available for trading by the public). This marks a 30.92% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.1, indicating that it would take 7.1 days of the average trading volume of 2.82 million shares to cover all short positions.Current Short Interest11,220,000 sharesPrevious Short Interest8,570,000 sharesChange Vs. Previous Month+30.92%Dollar Volume Sold Short$39.49 millionShort Interest Ratio7.1 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares160,028,000 sharesFloat Size155,770,000 sharesShort Percent of Float7.20%Today's Trading Volume143,236 sharesAverage Trading Volume2,820,759 sharesToday's Volume Vs. Average5% Short Selling Ironwood Pharmaceuticals? Sign up to receive the latest short interest report for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIRWD Short Interest Over TimeIRWD Days to Cover Over TimeIRWD Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Ironwood Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202411,220,000 shares $39.49 million +30.9%7.2%7.1 $3.52 11/15/20248,570,000 shares $36.08 million -21.8%5.5%5.3 $4.21 10/31/202410,960,000 shares $43.29 million -8.1%7.0%6.6 $3.95 10/15/202411,930,000 shares $52.37 million +1.2%7.7%6.3 $4.39 9/30/202411,790,000 shares $48.57 million +1.6%7.6%5.9 $4.12 9/15/202411,610,000 shares $53.06 million -14.6%7.5%5.7 $4.57 Get the Latest News and Ratings for IRWD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/202413,600,000 shares $68.82 million -2.9%8.7%5.9 $5.06 8/15/202414,000,000 shares $62.30 million -11.4%9.0%6 $4.45 7/31/202415,800,000 shares $107.91 million -6.2%10.2%6.3 $6.83 7/15/202416,850,000 shares $109.19 million -6.8%10.9%6.8 $6.48 6/30/202418,070,000 shares $117.82 million -10.6%11.7%6.9 $6.52 6/15/202420,220,000 shares $117.88 million -10.8%13.1%7.3 $5.83 5/31/202422,660,000 shares $142.76 million +0.8%14.6%6.9 $6.30 5/15/202422,480,000 shares $147.47 million +12.0%14.5%5.2 $6.56 4/30/202420,080,000 shares $155.62 million -5.1%13.0%4.5 $7.75 4/15/202421,160,000 shares $164.84 million -3.6%14.0%4.6 $7.79 3/31/202421,950,000 shares $191.18 million +16.9%14.5%4.6 $8.71 3/15/202418,770,000 shares $169.31 million +21.0%12.4%4 $9.02 2/29/202415,510,000 shares $146.26 million -0.6%10.2%3.8 $9.43 2/15/202415,600,000 shares $233.84 million +7.9%10.3%5.5 $14.99 1/31/202414,460,000 shares $205.19 million -10.1%9.5%5.4 $14.19 1/15/202416,080,000 shares $195.37 million +2.0%12.8%6.5 $12.15 12/31/202315,760,000 shares $180.29 million -7.3%10.3%7.4 $11.44 12/15/202317,000,000 shares $189.21 million +2.3%11.2%7.8 $11.13 11/30/202316,620,000 shares $164.54 million -3.1%10.9%6.8 $9.90 11/15/202317,150,000 shares $167.38 million -1.4%11.3%6.9 $9.76 10/31/202317,390,000 shares $155.99 million -0.9%11.4%6.7 $8.97 10/15/202317,540,000 shares $164.00 million -0.6%11.5%6.8 $9.35 9/30/202317,640,000 shares $169.87 million +20.3%11.6%7.1 $9.63 9/15/202314,660,000 shares $122.26 million -5.4%9.6%6.1 $8.34 8/31/202315,500,000 shares $136.40 million +3.9%10.2%7.2 $8.80 8/15/202314,920,000 shares $147.11 million -1.8%9.8%7.1 $9.86 7/31/202315,190,000 shares $168.46 million -6.5%10.0%7.3 $11.09 7/15/202316,250,000 shares $168.35 million +13.5%10.7%7.9 $10.36 6/30/202314,320,000 shares $152.36 million -17.9%9.5%6.4 $10.64 6/15/202317,450,000 shares $192.47 million -1.0%11.5%7 $11.03 5/31/202317,620,000 shares $191.71 million +6.4%11.6%7.3 $10.88 5/15/202316,560,000 shares $174.38 million -3.3%10.9%6.7 $10.53 4/30/202317,130,000 shares $178.32 million -14.9%11.3%7.3 $10.41 4/15/202320,130,000 shares $221.23 million +14.1%13.4%8.8 $10.99Could this be the hottest crypto discovery of all time? (Ad)I want to let you in on what may be the hottest crypto discovery of all time… One that has NOTHING to do with creating a crypto wallet or touching ANY risky coin for that matter. Instead, it’s a way that could let regular folks like you and me target 10X the possible results you’d expect from buying Bitcoin … in just a fraction of the time It sounds nuts… trust me I know that… But just as I would hate for you to jump into any risky crypto asset… That’s exactly how I would hate for you to miss out on what could be a safer and better way to benefit from the crypto bull run of 2024. Which is why I’m giving you an opportunity to get all the details of this iconic crypto discovery with you for the first time ever… completely free…If you want in, Just Click Here 3/31/202317,640,000 shares $185.57 million +8.0%11.8%7.6 $10.52 3/15/202316,330,000 shares $170.32 million +1.0%10.9%8.4 $10.43 2/28/202316,170,000 shares $182.24 million +1.4%10.7%8.3 $11.27 2/15/202315,950,000 shares $178.64 million -0.1%10.6%8.4 $11.20 1/31/202315,970,000 shares $183.97 million +0.1%10.7%8.5 $11.52 1/15/202315,950,000 shares $184.86 million -2.6%10.7%8.7 $11.59 12/30/202216,370,000 shares $202.82 million -3.4%10.9%8.8 $12.39 12/15/202216,950,000 shares $204.25 million +2.8%11.4%8.9 $12.05 11/30/202216,490,000 shares $199.69 million -12.3%11.1%8.2 $12.11 11/15/202218,810,000 shares $214.62 million +9.7%12.6%8.9 $11.41 10/31/202217,150,000 shares $187.62 million -1.6%11.4%8.1 $10.94 10/15/202217,420,000 shares $175.77 million +0.2%11.7%7.5 $10.09 9/30/202217,390,000 shares $180.16 million -3.3%11.7%7.5 $10.36 9/15/202217,980,000 shares $196.16 million -1.1%12.1%7.6 $10.91 8/31/202218,170,000 shares $195.51 million -0.4%12.2%6 $10.76 8/15/202218,240,000 shares $217.24 million +0.9%12.3%5.5 $11.91 7/31/202218,080,000 shares $207.02 million +3.3%12.1%5.3 $11.45 7/15/202217,510,000 shares $203.99 million -6.1%11.7%5.4 $11.65 6/30/202218,650,000 shares $215.03 million +32.5%12.5%5.7 $11.53 6/15/202214,080,000 shares $163.05 million -4.1%9.4%4.3 $11.58 5/31/202214,680,000 shares $165.44 million -7.7%9.8%5.6 $11.27 5/15/202215,900,000 shares $184.28 million -2.8%10.6%6.5 $11.59 4/30/202216,350,000 shares $196.20 million -3.3%10.9%6.5 $12.00 4/15/202216,900,000 shares $208.21 million +5.3%10.9%6.6 $12.32 3/31/202216,050,000 shares $201.91 million +6.2%N/A6 $12.58 3/15/202215,110,000 shares $180.26 million +22.3%9.8%5.9 $11.93 2/28/202212,360,000 shares $132.99 million -6.5%8.0%5 $10.76 2/15/202213,220,000 shares $144.10 million -17.6%8.5%5.4 $10.90 1/31/202216,050,000 shares $178.96 million -3.7%10.1%7.1 $11.15 1/15/202216,670,000 shares $195.37 million -2.1%N/A7.5 $11.72 12/31/202117,030,000 shares $198.57 million -7.0%10.7%8.5 $11.66 12/15/202118,320,000 shares $207.93 million -11.3%11.5%8.9 $11.35 11/30/202120,650,000 shares $229.01 million -1.5%12.9%10.2 $11.09 11/15/202120,960,000 shares $255.50 million -7.0%13.1%11.2 $12.19 10/29/202122,540,000 shares $287.84 million +10.4%14.1%12.1 $12.77 10/15/202120,420,000 shares $278.94 million -0.1%12.9%12 $13.66 9/30/202120,430,000 shares $266.82 million +2.0%12.9%11.7 $13.06 9/15/202120,040,000 shares $242.28 million -4.1%12.6%11.1 $12.09 8/31/202120,890,000 shares $273.66 million +0.2%13.2%11.2 $13.10 8/13/202120,850,000 shares $284.39 million +2.3%13.1%11 $13.64 7/30/202120,380,000 shares $270.44 million +4.1%12.8%10.5 $13.27 7/15/202119,570,000 shares $245.99 million -1.9%12.4%10.2 $12.57 6/30/202119,950,000 shares $256.76 million -3.7%12.6%10.7 $12.87 6/15/202120,710,000 shares $231.54 million +11.1%13.1%12.1 $11.18 5/28/202118,640,000 shares $215.66 million -4.3%11.8%10.5 $11.57 5/14/202119,480,000 shares $223.63 million +6.4%N/A9.2 $11.48 4/30/202118,310,000 shares $206.17 million +0.9%N/A8.5 $11.26 4/15/202118,150,000 shares $192.93 million -6.9%N/A8.3 $10.63 3/31/202119,490,000 shares $213.42 million -5.0%12.6%8.8 $10.95 3/15/202120,510,000 shares $231.97 million +14.5%13.2%9.7 $11.31Could this be the hottest crypto discovery of all time? (Ad)I want to let you in on what may be the hottest crypto discovery of all time… One that has NOTHING to do with creating a crypto wallet or touching ANY risky coin for that matter. Instead, it’s a way that could let regular folks like you and me target 10X the possible results you’d expect from buying Bitcoin … in just a fraction of the time It sounds nuts… trust me I know that… But just as I would hate for you to jump into any risky crypto asset… That’s exactly how I would hate for you to miss out on what could be a safer and better way to benefit from the crypto bull run of 2024. Which is why I’m giving you an opportunity to get all the details of this iconic crypto discovery with you for the first time ever… completely free…If you want in, Just Click Here 2/26/202117,910,000 shares $161.91 million -1.4%11.5%9.2 $9.04 2/12/202118,170,000 shares $183.88 million +5.5%11.7%12 $10.12 1/29/202117,230,000 shares $181.86 million -5.7%11.1%10.5 $10.56 1/15/202118,270,000 shares $207.00 million -0.4%11.8%10.9 $11.33 12/31/202018,340,000 shares $211.09 million -7.0%11.9%11.2 $11.51 12/15/202019,720,000 shares $240.49 million -3.6%12.7%9.7 $12.20 11/30/202020,450,000 shares $241.92 million +0.3%13.2%10.1 $11.83 11/15/202020,380,000 shares $237.63 million -7.9%13.2%10 $11.66 10/30/202022,120,000 shares $212.79 million +5.0%14.3%10.9 $9.62 10/15/202021,060,000 shares $206.18 million +2.2%13.7%10.6 $9.79 9/30/202020,600,000 shares $185.30 million -1.0%13.4%10.4 $9.00 9/15/202020,800,000 shares $211.12 million -2.5%13.5%12.6 $10.15 8/31/202021,330,000 shares $215.43 million -13.4%13.8%11.5 $10.10 8/14/202024,620,000 shares $244.97 million +3.8%16.0%11.3 $9.95 7/31/202023,730,000 shares $217.60 million -4.5%15.4%10.6 $9.17 7/15/202024,840,000 shares $253.86 million -6.5%16.2%11.7 $10.22 6/30/202026,560,000 shares $270.38 million +5.7%17.3%12.7 $10.18 6/15/202025,120,000 shares $233.87 million +3.6%16.4%11.6 $9.31 5/29/202024,250,000 shares $236.44 million -3.7%15.8%11.4 $9.75 5/15/202025,170,000 shares $280.02 million +0.6%16.4%12.4 $11.13 4/30/202025,020,000 shares $250.20 million -4.3%16.3%12.6 $10.00 4/15/202026,140,000 shares $261.66 million -3.9%17.0%13.7 $10.01 3/31/202027,200,000 shares $279.62 million -2.9%17.8%13.5 $10.28 3/13/202027,996,800 shares $272.97 million -3.3%18.3%14.6 $9.75 2/28/202028,950,000 shares $277.92 million +0.8%18.9%15.6 $9.60 2/14/202028,710,000 shares $328.73 million +0.1%18.7%16.1 $11.45 1/31/202028,670,000 shares $317.38 million -0.7%18.9%17.3 $11.07 1/15/202028,870,000 shares $351.64 million +0.7%19.0%16.9 $12.18 12/31/201928,670,000 shares $354.65 million +4.8%18.9%17.8 $12.37 IRWD Short Interest - Frequently Asked Questions What is Ironwood Pharmaceuticals' current short interest? Short interest is the volume of Ironwood Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 11,220,000 shares of IRWD short. 7.20% of Ironwood Pharmaceuticals' shares are currently sold short. Learn More on Ironwood Pharmaceuticals' current short interest. What is a good short interest ratio for Ironwood Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IRWD shares currently have a short interest ratio of 7.0. Learn More on Ironwood Pharmaceuticals's short interest ratio. What is a good short interest percentage for Ironwood Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.20% of Ironwood Pharmaceuticals' floating shares are currently sold short. Is Ironwood Pharmaceuticals' short interest increasing or decreasing? Ironwood Pharmaceuticals saw a increase in short interest in November. As of November 30th, there was short interest totaling 11,220,000 shares, an increase of 30.9% from the previous total of 8,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ironwood Pharmaceuticals' float size? Ironwood Pharmaceuticals currently has issued a total of 160,028,000 shares. Some of Ironwood Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ironwood Pharmaceuticals currently has a public float of 155,770,000 shares. How does Ironwood Pharmaceuticals' short interest compare to its competitors? 7.20% of Ironwood Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Ironwood Pharmaceuticals: Geron Co. (10.98%), Ligand Pharmaceuticals Incorporated (4.16%), MannKind Co. (15.61%), Celldex Therapeutics, Inc. (11.61%), Dynavax Technologies Co. (13.62%), BioCryst Pharmaceuticals, Inc. (9.35%), Novavax, Inc. (24.83%), Myriad Genetics, Inc. (3.72%), Innoviva, Inc. (17.34%), OPKO Health, Inc. (31.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Ironwood Pharmaceuticals stock? Short selling IRWD is an investing strategy that aims to generate trading profit from Ironwood Pharmaceuticals as its price is falling. IRWD shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ironwood Pharmaceuticals? A short squeeze for Ironwood Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IRWD, which in turn drives the price of the stock up even further. How often is Ironwood Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IRWD, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Geron Short Interest Ligand Pharmaceuticals Short Interest MannKind Short Interest Celldex Therapeutics Short Interest Dynavax Technologies Short Interest BioCryst Pharmaceuticals Short Interest Novavax Short Interest Myriad Genetics Short Interest Innoviva Short Interest OPKO Health Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IRWD) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
